Korean Medication Algorithm for Depressive Disorders 2017: Third Revision-Reference-Cited by-同舟云学术

Korean Medication Algorithm for Depressive Disorders 2017: Third Revision

Published:2018-02-28 Issue:1 Volume:16 Page:67-87
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Seo Jeong Seok¹,Bahk Won-Myong²,Wang Hee Ryung²,Woo Young Sup²,Park Young-Min³,Jeong Jong-Hyun²,Kim Won⁴⁵,Shim Se-Hoon⁶,Lee Jung Goo⁷⁸,Jon Duk-In⁹,Min Kyung Joon¹⁰

Affiliation:

1. Department of Psychiatry, Konkuk University School of Medicine, Cheongju, Korea

2. Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea

3. Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea

4. Department of Psychiatry, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea

5. Korea/Stress Research Institute, Inje University, Seoul, Korea

6. Department of Psychiatry, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea

7. Department of Psychiatry, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea

8. Paik Institute for Clinical Research, Department of Health Science and Technology, Graduate School of Inje University, Busan, Korea

9. Department of Psychiatry, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea

10. Department of Psychiatry, Chung-Ang University College of Medicine, Seoul, Korea

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health

Link

http://pdf.medrang.co.kr/CPN2/2018/016/cpn016-01-09.pdf

Reference77 articles.

1. Field, M, and Lohr, KN (1992). Guidelines for clinical practice: from development to use. Washington, D.C: National Academy Press, pp. 32-35

2. The Korean medication algorithm for depressive disorder: Second revision

3. Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients

4. The Korean Medication Algorithm for Major Depressive Disorder (KMA-MDD): Report of the Korean Society of Depressive and Bipolar Disorders

5. Seo, JS, Min, KJ, Kim, W, Seok, JH, Bahk, WM, and Song, HC (2007). Korean medication algorithm for depressive disorder 2006 (I). J Korean Neuropsychiatr Assoc. 46, 453-460.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence trend and epidemiology of tic disorders among youths and adults in Korea from 2003 to 2020: A national population-based study;Psychiatry Research;2024-01

2. Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial;Clinical Psychopharmacology and Neuroscience;2023-02-28

3. The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions;Journal of Clinical Medicine;2023-02-01

4. Concordance of the treatment patterns for major depressive disorders between the Canadian Network for Mood and Anxiety Treatments (CANMAT) algorithm and real-world practice in China;Frontiers in Pharmacology;2022-08-31

5. Efficacy and safety of Gyejibokryeong-hwan (GBH) in major depressive disorder: study protocol for multicentre randomised controlled trial;Trials;2022-06-01